Clementia
IPOPublic · Montreal, Canada · Founded 2013 · $92.5M raised
- Headquarters
- Montreal
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- clementiapharma.com
- Total Funding
- $92.5M
- Last Round
- $60.0M Venture RoundJun 2015
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clementia Pharmaceuticals was a Montreal-based rare disease biopharmaceutical company founded in 2011. Its lead compound palovarotene, a retinoic acid receptor gamma agonist, was in clinical development for fibrodysplasia ossificans progressiva and multiple osteochondromas. Clementia was acquired by Ipsen in 2019 for approximately $1.3 billion.
Summary
Clementia is a Biotech company based in Montreal, Canada, founded in 2013. It has raised $92.5M in total across 3 rounds, most recently a $60.0M Venture Round in Jun 2015. Investors include OrbiMed, New Enterprise Associates and UCB.
Tech & App Stack
15 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Aug 2017
Sign up to see all 4 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/clementia"><img src="https://indexed.vc/api/badge/company/clementia" alt="Clementia on Indexed.vc" width="260" height="76" /></a>